XML 45 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
6 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
September 30, 2021March 31, 2021
Redeemable convertible preferred stock— 76,287 
Common stock warrants1,450 250 
2010 Equity Incentive Plan
Options outstanding30,054 33,856 
Shares available for future grant— 1,550 
2021 Stock Option and Incentive Plan
Performance-based restricted stock units outstanding
15 — 
Restricted stock units outstanding
220 — 
Shares available for future grant22,397 — 
2021 ESPP4,500 — 
Options outstanding outside the Plans2,709 2,720 
Total61,345 114,663 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in thousands, except per share information):
Number of SharesWeighted-
Average
Exercise
Price
Average
Remaining
Contractual
Term
(in years)
Aggregate Intrinsic Value
Balance, March 31, 202136,576 $2.80 7.86$357,366 
Options granted1,966 12.56 
Options exercised(5,446)0.93 
Options forfeited or expired(333)3.24 
Balance, September 30, 202132,763 3.69 7.802,523,152 
Vested and exercisable as of September 30, 202110,232 1.18 5.84813,709 
Vested and expected to vest as of September 30, 202129,765 3.55 7.672,296,324 
Stock Options Valuation Assumptions
The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:
Six Months Ended September 30,
20212020
Fair value of common stock$18.41 $21.41 $2.06 $4.09 
Volatility46.5 %47.0 %51.3 %58.3 %
Risk-free interest rate0.77 %1.02 %0.26 %0.46 %
Expected term (in years)5.006.095.007.50
Expected dividend—%—%
Restricted Stock Unit Activity The following table summarizes RSU activity during the six months ended September 30, 2021 (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested Balance, March 31, 2021— $— 
Granted224 76.60 
Vested(4)80.00 
Unvested Balance, September 30, 2021220 76.58 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the condensed consolidated statement of operations for the three and six months ended September 30, 2021 and 2020 was as follows (in thousands):
Three Months Ended September 30,Six Months Ended September 30,
2021202020212020
Cost of revenue$793 $99 $1,061 $189 
Research and development1,859 281 2,829 545 
Sales and marketing1,866 376 2,894 671 
General and administrative2,154 423 5,015 757 
Total stock-based compensation expense$6,672 $1,179 $11,799 $2,162